Sorafenib triggers ferroptosis via inhibition of HBXIP/SCD axis in hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sorafenib triggers ferroptosis via inhibition of HBXIP/SCD axis in hepatocellular carcinoma

Published:2022-09-15 Issue:3 Volume:44 Page:622-634
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Zhang Lu,Li Xian-meng,Shi Xu-he,Ye Kai,Fu Xue-li,Wang Xue,Guo Shi-man,Ma Jia-qi,Xu Fei-fei,Sun Hui-min,Li Qian-qian,Zhang Wei-ying,Ye Li-hong

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.nature.com/articles/s41401-022-00981-9.pdf

Reference43 articles.

1. Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380:1450–62.

2. Su Y, Zhao B, Zhou L, Zhang Z, Shen Y, Lv H, et al. Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs. Cancer Lett. 2020;483:127–36.

3. Dolma S, Lessnick SL, Hahn WC, Stockwell BR. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3:285–96.

4. Yu Y, Xie Y, Cao L, Yang L, Yang M, Lotze MT, et al. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol Cell Oncol. 2015;2:e1054549.

5. Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R, et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2016;63:173–84.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms and therapeutic target of anti-tumour treatment-related Ferroptosis: How to improve cancer therapy?;Biomedicine & Pharmacotherapy;2024-10

2. Ferroptosis in Renal Cancer Therapy: A Narrative Review of Drug Candidates;Cancers;2024-09-11

3. Crizotinib and its enantiomer suppress ferroptosis by decreasing PE-O-PUFA content;Cell Death Discovery;2024-08-12

4. Programmed cell death in hepatocellular carcinoma: mechanisms and therapeutic prospects;Cell Death Discovery;2024-08-08

5. Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease;Metabolism;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3